No Detail Found!

Efficacy and safety of mesenchymal stem cell in Chinese patients with chronic renal failure: A pilot study in Shandong province, China

Author(s)
Zhuling Shao Department of emergency, The third Linyi People's Hospital,Linyi, Shandong,China
Xiangling Meng Department of General Thoracic Surgery, The third Linyi People's Hospital,Linyi, Shandong,China
Fanchao Meng Department of emergency, The third Linyi People's Hospital,Linyi, Shandong,China
Abstract
This study designed to evaluate efficacy and safety profile of Mesenchymal stem cells (MSCs) versus Acetyl cysteine (NACys) in the Chinese patients with Chronic renal failure (CRF). The CRF patients having eGFR less than 60ml per minute per 1.73m2 randomly assigned to MSCs (N=100) or NACys (N=100) (1:1) for 8 weeks. MSCs administered as intravenous infusion of marrow-derived autologous MSCs (1?×?106 to 2?×?106/kg) reperfusion, whereas, another group received NACys 600mg orally twice a day for 8 weeks. The efficacy variables include: creatinine; cystatin C; TGF-ß levels; oxidants/reactive oxygen species production induced by TGF-ß; collagen levels (type 1 and 4); urinary albumin/creatinine ratio and Glomerular area. Safety was also assesed. Both the treatments significantly decreased creatinine, cystatin C and reactive oxygen species from baseline, however, reduction in creatinine, cystatin C, and reactive oxygen species level from baseline was significantly higher in patient treated with MSCs (N=100) as compared to NACys (N=100). Moreover, improvement in renal and systemic functional parameters from baseline was significantly higher in patient treated with MSCs as compared to NACys. Overall, MSCs offer significantly greater improvement in renal function as compared to NACys in Chinese CRF patients.
Publication Details
Page(s) 1227-1231
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S3, Year: 2021

Request the full text from PASTIC

Keywords
Creatinine, Acetyl cysteine, Chronic renal failure, Renal function, Mesenchymal stem cells, Cystatin C
References
Chen C .2016 .Mesenchymal stem cell-based therapy in kidney transplantation. Stem. Cell. Res. Ther., 7(7) : 16.
Christian S,Poliana ES,Maria TR,Oliveira L,Bevilaqua ER .2020 .Mesenchymal stem cell therapy in acute kidney injury (AKI): Review and perspectives. Rev. Assoc. Med, 66(1) : s45-s54.
Naicker S Diana N .2016 .Update on current management of chronic kidney disease in patients with HIV infection. Int. J. Nephrol. Renovasc Dis, 9 : 223-234.
Gilbertson DT,Liu J,Xue JL,Louis TA,Solid CA,Ebben JP,Collins AJ .2015 .Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J. Am. Soc. Nephrol., 16(12) : 3736-3741.
Kim JS,Lee JH,Kwon O .2017 .Rapid deterioration of pre-existing renal insufficiency after autologous mesenchymal stem cell therapy. Kidney Res. Clin. Pract, 36(2) : 200-204.
Makhlough A,Shekarchian S,Moghadasali R .2018 .Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up. Cytotherapy, 20 : 660-669.
Morigi M,Rota C,Remuzzi G C .2016 .Mesenchymal stem cells in kidney repair. Methods Mol Biol, 1416 : 89-107.
Pan XH,Zhou J .2017 .Transplantation of induced mesenchymal stem cells for treating chronic renal insufficiency. PLoS One, 12(4) : e0176273.
Papazova DA,Oosterhuis NR,Gremmels H,van Koppen A,Joles JA,Verhaar MC .2015 .Cell-based therapies for experimental chronic kidney disease: A systematic review and meta-analysis. Dis Model Mech., 8(3) : 281-293.
Tariq R,Jason F,Richard S F .2008 .N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. CJASN, 3(6) : 1610-1614.
Urt-Filho A,Oliveira RJ,Hermeto LC .2016 .Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model. Mol. Biol, 39(2) : 290-299.
Villanueva S,González F,Lorca E F .2019 .Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: a pilot study assessing safety and clinical feasibility. Kidney Res. Clin. Pract, 38(2) : 176-185.
0

Citations

0

Downloads

14

Views